Karen Kemp

1.6k total citations
37 papers, 987 citations indexed

About

Karen Kemp is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Karen Kemp has authored 37 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 15 papers in Epidemiology and 7 papers in Surgery. Recurrent topics in Karen Kemp's work include Inflammatory Bowel Disease (24 papers), Microscopic Colitis (15 papers) and Eosinophilic Esophagitis (4 papers). Karen Kemp is often cited by papers focused on Inflammatory Bowel Disease (24 papers), Microscopic Colitis (15 papers) and Eosinophilic Esophagitis (4 papers). Karen Kemp collaborates with scholars based in United Kingdom, Denmark and Netherlands. Karen Kemp's co-authors include Tamar Mendelson, Deborah F. Perry, S. Darius Tandon, Julie A. Leis, Simon Campbell, Jane Griffiths, Karina Lovell, Palle Bager, C. Janneke van der Woude and Silvio Danese and has published in prestigious journals such as Gastroenterology, Gut and Journal of Consulting and Clinical Psychology.

In The Last Decade

Karen Kemp

35 papers receiving 958 citations

Peers

Karen Kemp
Lesley Dibley United Kingdom
Andreas Nydegger Switzerland
Tiffany Taft United States
Sarah Corathers United States
Andrew McCombie New Zealand
M.K.A. Basra United Kingdom
S. Gene McNeeley United States
Karen Kemp
Citations per year, relative to Karen Kemp Karen Kemp (= 1×) peers Shirley Cohen‐Mekelburg

Countries citing papers authored by Karen Kemp

Since Specialization
Citations

This map shows the geographic impact of Karen Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Kemp more than expected).

Fields of papers citing papers by Karen Kemp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Kemp. The network helps show where Karen Kemp may publish in the future.

Co-authorship network of co-authors of Karen Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Kemp. A scholar is included among the top collaborators of Karen Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Kemp. Karen Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Alexander C., Matthew Brookes, Elspeth Guthrie, et al.. (2025). Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT. Health Technology Assessment. 1–30. 1 indexed citations
2.
Kemp, Karen, Mark Samaan, Ajay Verma, & Alan Lobo. (2024). Crohn’s disease management: translating STRIDE-II for UK clinical practice. Therapeutic Advances in Gastroenterology. 17. 1118463861–1118463861.
3.
Kemp, Karen, et al.. (2023). Clinical service delivery implications of the COVID-19 pandemic on people with Inflammatory bowel disease: a qualitative study. BMC Health Services Research. 23(1). 1195–1195. 1 indexed citations
4.
Kemp, Karen, Lesley Dibley, Usha Chauhan, et al.. (2018). 2nd N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn's Disease or Ulcerative Colitis. Greenwich Academic Literature Archive (University of Greenwich). 32 indexed citations
5.
Danese, Silvio, Gionata Fiorino, Tim Raine, et al.. (2016). ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update. Journal of Crohn s and Colitis. 11(1). 26–34. 171 indexed citations
6.
Kemp, Karen, et al.. (2016). PTH-060 Better Care for IBD Biologic Patients: The Impact of A Multi-Disciplinary Virtual Clinic. A248.2–A249. 1 indexed citations
7.
Dibley, Lesley, Palle Bager, Wladyslawa Czuber‐Dochan, et al.. (2016). Identification of Research Priorities for Inflammatory Bowel Disease Nursing in Europe: a Nurses-European Crohn’s and Colitis Organisation Delphi Survey. Journal of Crohn s and Colitis. 11(3). jjw164–jjw164. 34 indexed citations
8.
Irving, Peter M., Charlie W. Lees, Ailsa Hart, et al.. (2016). PTH-080 Serious Infusion Reactions with Vedolizumab are Rare: A UK Multicenter Experience. A258.2–A259.
9.
Hart, Ailsa, Miranda Lomer, Azmina Verjee, et al.. (2016). What Are the Top 10 Research Questions in the Treatment of Inflammatory Bowel Disease? A Priority Setting Partnership with the James Lind Alliance. Journal of Crohn s and Colitis. 11(2). 204–211. 85 indexed citations
10.
Wilburn, Jeanette, Stephen P. McKenna, James Twiss, Karen Kemp, & Simon Campbell. (2015). Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ). Quality of Life Research. 24(9). 2279–2288. 40 indexed citations
11.
Kemp, Karen, et al.. (2014). N-ECCO survey results of nursing practice in caring for patients with Crohn's disease or ulcerative colitis in Europe. Journal of Crohn s and Colitis. 8(10). 1300–1307. 22 indexed citations
12.
Wilburn, Jeanette, Stephen P. McKenna, James Twiss, Karen Kemp, & S. Campbell. (2013). PTU-080 Development and Validation of the Crohn’S Life Impact Questionnaire (Cliq). Gut. 62(Suppl 1). A79.1–A79. 2 indexed citations
13.
Kemp, Karen, Jane Griffiths, Simon Campbell, & Karina Lovell. (2013). An exploration of the follow-up up needs of patients with inflammatory bowel disease. Journal of Crohn s and Colitis. 7(9). e386–e395. 106 indexed citations
14.
Tandon, S. Darius, Julie A. Leis, Tamar Mendelson, Deborah F. Perry, & Karen Kemp. (2013). Six-Month Outcomes from a Randomized Controlled Trial to Prevent Perinatal Depression in Low-Income Home Visiting Clients. Maternal and Child Health Journal. 18(4). 873–881. 91 indexed citations
15.
Kemp, Karen, et al.. (2013). A competency framework for inflammatory bowel disease nurses. Nursing Standard. 27(38). 41–45. 3 indexed citations
17.
Kemp, Karen. (2012). Understanding the health and social care needs of people living with IBD: A meta-synthesis of the evidence. World Journal of Gastroenterology. 18(43). 6240–6240. 83 indexed citations
18.
Tandon, S. Darius, Deborah F. Perry, Tamar Mendelson, Karen Kemp, & Julie A. Leis. (2011). Preventing perinatal depression in low-income home visiting clients: A randomized controlled trial.. Journal of Consulting and Clinical Psychology. 79(5). 707–712. 87 indexed citations
19.
Kemp, Karen, Martyn Dibb, Alistair Makin, & S. Campbell. (2009). P042 - 2 year follow up of adalimumab therapy in patients with Crohn's disease. Journal of Crohn s and Colitis. 3(1). S27–S28. 3 indexed citations
20.
Maglinte, Dean D. T., Frederick M. Kelvin, Young Joo Suh, & Karen Kemp. (2002). Does the addition of an oral barium tracer improve the ability of the preliminary abdominal radiograph to assess efficacy of colonic cleansing? A prospective randomized controlled evaluation. Abdominal Imaging. 27(4). 448–452. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026